Impact of Vaccines Across the Lifespan: A New Perspective in Public Health—Conclusions of an Expert Panel—Part 1 †

Debbag R.; Ávila-Agüero M.L.; Brea J.; Espinal C.; Romero-Feregrino R.; Torres J.R.; Vázquez H.; Cuadros R.; Lazo-Páez G.; Schilling A.; Bonvehí P.; Kairalla M.; Rodríguez-Morales A.J. · Vaccines (2026) · DOI: 10.3390/vaccines14020183

Resumen

Population aging is the most significant demographic transformation of the 21st century, reshaping health systems, economies, and societies. The biological processes of immunosenescence and inflammaging weaken host defenses, reduce vaccine effectiveness, and increase vulnerability to infectious and chronic diseases. These changes underscore the urgent need for preventive strategies that extend beyond childhood immunization. Vaccination is a cornerstone of healthy aging, capable of preventing infections and has been associated with reductions in systemic inflammation, frailty, and loss of functional independence in later life. Furthermore, new insights into vaccine-mediated immunomodulation, including trained immunity, adjuvanted formulations, and epigenetic reprogramming, highlight the evolving role of vaccines as modulators of immune fitness across the lifespan. This first part of our review examines the intersection of aging and immunity, as well as the potential of vaccines to address these challenges. Part 2 will expand on specific vaccines, proposed vaccination schedules, and global perspectives for lifelong immunization.

Instituciones: Universidad Científica del Sur